Chemours Co News - August 2026
Chemours Misses on Revenue and Earnings While Bleeding Red Ink — Can Cost Cuts and Debt Paydowns Outrun a Weakening Demand Cycle?
Shares of Chemours cratered nearly 10% after the specialty chemicals maker delivered a second quarter that fell short on virtually every line that matters to...
🔴 Chemours is trading 11% down today after Q2 earnings miss and lowered Q3 guidance
Chemours is trading 11% down at $15.95 after reporting second-quarter 2026 results that missed analyst estimates for both revenue and earnings per share. •...
🔴 Chemours is trading 13% down today after missing Q2 estimates and issuing soft Q3 guidance
Chemours is trading 13% down at $15.60 after missing Q2 2026 revenue and EPS expectations and issuing soft Q3 guidance. • The company reported a large GAAP...
🔴 Chemours is trading 10.1% down today after Q2 earnings miss and weak Q3 EBITDA outlook
Chemours is trading 10.1% down at $16.12 after missing Q2 2026 revenue and EPS expectations and issuing a soft outlook for the upcoming quarter. • The company...
🔴 Chemours is trading 9.8% down today after missing Q2 revenue and EPS expectations
Chemours is trading 9.8% down at $16.17 after reporting second-quarter 2026 results that missed revenue and EPS expectations. • While the company posted an...
Chemours' second quarter revenue misses estimates, but Adjusted EBITDA beats on pricing strength and APM growth.
The Chemours Company reported second quarter 2026 net sales of $1.59 billion, a 1% decrease year-over-year, missing analyst expectations. The company posted an...
Chemours Co Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
Chemours Co is projected to report Q2 2026 revenue of $1.66 billion and earnings per share of $0.43, while the stock currently trades at $17.09 compared to an...